COLUMVI (glofitamab-gxbm) is an innovative prescription medicine approved for the treatment of adults with relapsed or refractory diffuse…
Elosulfase alfa, marketed under the brand name Vimizim™, is a recombinant form of the enzyme N-acetylgalactosamine-6-sulfatase, manufactured by…
Blincyto is a prescription medicine with the active ingredient blinatumomab (API). It belongs to the class of monoclonal…